Rational Drug Use Evaluation Based on World Health Organization Core Drug Use Indicators in Ethiopia: A Systematic Review

References

• Organization WH. Promoting Rational Use of Medicines: Core Components. World Health Organization; 2002.
   Google Scholar
• Ofori-Asenso R, Agyeman AA. Irrational use of medicines—a summary of key concepts. Pharmacy. 2016;4(4):35. doi:10.3390/pharmacy4040035
   Web of Science ®Google Scholar
• Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med. 2010;35(1):10. doi:10.4103/0970-0218.62546
   PubMedGoogle Scholar
• Koyuncuoglu CZ, Aydin M, Kirmizi NI, et al. Rational use of medicine in dentistry: do dentists prescribe antibiotics in appropriate indications? Eur J Clin Pharmacol. 2017;73(8):1027–1032. doi:10.1007/s00228-017-2258-7
   Web of Science ®Google Scholar
• Selection WECot, Medicines UoE, Organization WH. The Selection and Use of Essential Medicines: Report of the WHO Expert Committee, 2013 (Including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children). World Health Organization; 2014.
   Google Scholar
• Bbosa GS, Wong G, Kyegombe DB, Ogwal-Okeng J. Effects of intervention measures on irrational antibiotics/antibacterial drug use in developing countries: a systematic review. Health. 2014;06(02):171–187. doi:10.4236/health.2014.62027
   Google Scholar
• Young M, Wolfheim C, Marsh DR, Hammamy D. World Health Organization/United Nations Children’s fund joint statement on integrated community case management: an equity-focused strategy to improve access to essential treatment services for children. Am J Trop Med Hyg. 2012;87(5_Suppl):6–10. doi:10.4269/ajtmh.2012.12-0221
   Web of Science ®Google Scholar
• Almarsdóttir AB, Traulsen JM. Rational use of medicines – an important issue in pharmaceutical policy. Pharm World Sci. 2005;27(2):76–80. doi:10.1007/s11096-005-3303-7
   Google Scholar
• Jain S, Upadhyaya P, Goyal J, et al. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Perspect Clin Res. 2015;6(2):86. doi:10.4103/2229-3485.154005
   PubMedGoogle Scholar
• Organization WH. WHO Biennial Report: Rwanda Country Office 2012–2013. 2014.
   Google Scholar
• Chauhan I, Yasir M, Kumari M, Verma M. The pursuit of rational drug use: understanding factors and interventions. Pharmaspire. 2018;10(2):48.
   Google Scholar
• Pronovost PJ. Enhancing physicians’ use of clinical guidelines. JAMA. 2013;310(23):2501–2502. doi:10.1001/jama.2013.281334
   PubMed Web of Science ®Google Scholar
• Kamarudin G, Penm J, Chaar B, Moles R. Educational interventions to improve prescribing competency: a systematic review. BMJ Open. 2013;3(8):e003291. doi:10.1136/bmjopen-2013-003291
   PubMed Web of Science ®Google Scholar
• Burrone E, Gotham D, Gray A, et al. Patent pooling to increase access to essential medicines. Bull World Health Organ. 2019;97(8):575. doi:10.2471/BLT.18.229179
   PubMed Web of Science ®Google Scholar
• Organization WH. Promoting Access, Quality and Innovation to Save and Improve Lives: Essential Medicines and Health Products. World Health Organization; 2016.
   Google Scholar
• Ocan M, Obuku EA, Bwanga F, et al. Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health. 2015;15(1):1–11. doi:10.1186/s12889-015-2109-3
   Web of Science ®Google Scholar
• Mao W, Tang S, Chen W. Does perverse economic incentive lead to the irrational uses of medicines? Expert Rev Pharmacoecon Outcomes Res. 2013;13(6):693–696. doi:10.1586/14737167.2013.856266
   PubMed Web of Science ®Google Scholar
• Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorb. 2011;1(1):28–44. doi:10.15256/joc.2011.1.4
   Google Scholar
• Olivier C, Williams-Jones B, Doize B, Ozdemir V. Containing global antibiotic resistance: ethical drug promotion in the developing world. In: Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P, Kariuki S, Okeke IN, editors. Antimicrobial Resistance in Developing Countries. Springer: New York; 2010:505–524.
   Google Scholar
• Atif M, Malik I, Dawoud D, Gilani A, Ahmed N, Babar Z-U-D. Essential medicine list, policies, and the World Health Organization. In: Babar ZUD, editor. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Oxford, UK: Elsevier; 2019:239–249.
   Google Scholar
• Organization WH. Primary Health Care Systems (‎‎‎ Primasys)‎‎‎: Case Study from Ethiopia. World Health Organization; 2017.
   Google Scholar
• Hettihewa LM, Isuru A, Kalana J. Prospective encounter study of the degree of adherence to patient care indicators related to drug dispensing in health care facilities: a Sri Lankan perspective. J Pharm Bioallied Sci. 2011;3(2):298. doi:10.4103/0975-7406.80769
   Google Scholar
• al. TADe. Assessment of drug use pattern using World Health Organization’s core drug use indicators at Debremarkose referal hospital, Northwest Ethiopia. IJIPSR. 2014;2(7):1270–1288.
   Google Scholar
• Angamo MT, Wabe NT, Raju N. Assessment of patterns of drug use by using World Health Organization’s prescribing, patient care and health facility indicators in selected health facilities in Southwest Ethiopia. J Appl Pharm Sci. 2011;1(7):62.
   Google Scholar
• Bilal AI, Osman ED, Mulugeta A. Assessment of medicines use pattern using World Health Organization’s prescribing, patient care and health facility indicators in selected health facilities in eastern Ethiopia. BMC Health Serv Res. 2016;16(1):1–8. doi:10.1186/s12913-016-1414-6
   PubMed Web of Science ®Google Scholar
• Gebramariam E, Ahmed M. Evaluation of rational medicine use based on WHO core drug use indicators in public hospitals in West Shoa Zone, Oromia, Ethiopia. Adv Pharmacoepidemiol Drug Saf. 2019;8(1):2167. doi:10.35248/2167-1052.19.8.225
   Google Scholar
• Getahun KA, Redia AS, Aragaw TJ. Evaluation of medicine-use pattern using World Health Organization’s core drug-use indicators and completeness of prescription at university of Gondar comprehensive specialized hospital, Gondar, Ethiopia: Cross-Sectional Study. Integr Pharm Res Pract. 2020;9:219. doi:10.2147/IPRP.S261320
   Web of Science ®Google Scholar
• Mamo DB, Alemu BK. Rational drug-use evaluation based on World Health Organization core drug-use indicators in a tertiary referral hospital, Northeast Ethiopia: a cross-sectional Study. Drug Healthc Patient Saf. 2020;12:15. doi:10.2147/DHPS.S237021
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O′ Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013.
   Google Scholar
• Assen A, Abrha S. Assessment of drug prescribing pattern in dessie referral hospital, dessie. Int J Pharm Sci Res. 2014;5(11):777–781.
   Google Scholar
• Assen M, Oumer S. Assessment of prescribing pattern in Bourumeda Hospital Northeast Ethiopia. Int J Pharm Sci Res. 2015;6(9):1214–1219.
   Google Scholar
• Dessie B, Atalaye G, Diress E, Getahun A. Practice towards rational drug use at finotselam and asirade zewudie hospitals based on WHO core drug use indicators, Northwest Ethiopia. Sci World J. 2020;2020:1–5. doi:10.1155/2020/1634294
   Google Scholar
• Desta Z, Abula T, Gebre-Yohannes A, Worku A. Drug prescribing patterns for outpatients in three hospitals in North-West Ethiopia. Ethiop J Health Dev. 2002;16(2):183–189. doi:10.4314/ejhd.v16i2.9809
   Google Scholar
• Lenjisa JL, Fereja TH. A retrospective analysis of prescribing practices through WHO prescribing indicators at four selected hospitals of West Ethiopia. J Bioanal Biomed. 2014;6(2):29.
   Google Scholar
• Ayen W. Base line survey on drug prescribing indicators for outpatient in Jimma University specialized hospital in South west Ethiopia. Ethiop J Health Sci. 2005;15(2):147–156.
   Google Scholar
• Mariam AH, Raghavendra Y, Bobasa EM. Evaluating rational drug use with the help of World Health Organization’s core indicators in Bule Hora Hospital, Southern Ethiopia. encounters. 2015;7(8):11.
   Google Scholar
• Teshale C, Hussein J, Mussa S. Assessment of the quality of pharmaceutical service in Jimma Zone, Oromia regional state, South West Ethiopia. Int J Pharm Teach Pract. 2014;5(2):1–6.
   Google Scholar
• Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013;13(1):1–6. doi:10.1186/1472-6963-13-170
   PubMed Web of Science ®Google Scholar
• Dilbato DD, Kuma ZG, Tekle-Mariam S. A baseline survey on prescribing indicators and the underlying factors influencing prescribing in Southern Ethiopia. Ethiop J Health Dev. 1998;12(2).
   Google Scholar
• Mensa M, Tadesse T, Ayele A. Assessment of drug use pattern by using WHO core drug use indicators at public hospitals in Ethiopia. J Community Med Health Educ. 2017;7(05):2161–2711. doi:10.4172/2161-0711.1000559
   Google Scholar
• Summoro TS, Gidebo KD, Kanche ZZ, Woticha EW. Evaluation of trends of drug-prescribing patterns based on WHO prescribing indicators at outpatient departments of four hospitals in southern Ethiopia. Drug Des Devel Ther. 2015;9:4551. doi:10.2147/DDDT.S83588
   Web of Science ®Google Scholar
• Yilma Z, Liben M. Assessment of drug prescription pattern in Mekelle general hospital, Mekelle, Ethiopia, using World Health Organization prescribing indicators. Biomed Res Int. 2020;2020:1–6. doi:10.1155/2020/3809157
   Web of Science ®Google Scholar
• Gashaw T, Sisay M, Mengistu G, Amare F. Investigation of prescribing behavior at outpatient settings of governmental hospitals in eastern Ethiopia: an overall evaluation beyond World Health Organization core prescribing indicators. J Pharm Policy Pract. 2018;11(1):1–11. doi:10.1186/s40545-018-0152-z
   Google Scholar
• Sisay M, Mengistu G, Molla B, Amare F, Gabriel T. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17(1):1–9. doi:10.1186/s12913-017-2097-3
   PubMed Web of Science ®Google Scholar
• Singh T, Banerjee B, Garg S, Sharma S. A prescription audit using the World Health Organization-recommended core drug use indicators in a rural hospital of Delhi. J Educ Health Promot. 2019;8:37.
   Google Scholar
• Organization WH. Using Indicators to Measure Country Pharmaceutical Situations: Fact Book on WHO Level I and Level II Monitoring Indicators. Using Indicators to Measure Country Pharmaceutical Situations: Fact Book on WHO Level I and Level II Monitoring Indicators. 2006:xviii, 84–xviii.
   Google Scholar
• Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16(1):1–14. doi:10.1186/s12889-016-3428-8
   PubMed Web of Science ®Google Scholar
• El Mahalli A. WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. East Mediterr Health J. 2012;18(11):1091–1096. doi:10.26719/2012.18.11.1091
   PubMedGoogle Scholar
• Sharif SI, Alabdouli AH, Sharif RS. Drug prescribing trends in a general hospital in Sharjah, United Arab Emirates. Am J Pharmacol Sci. 2013;1(1):6–9. doi:10.12691/ajps-1-1-2
   Google Scholar
• Fattouh R, Abu Hamad B. Impact of using essential drug list: analysis of drug use indicators in Gaza Strip. East Mediterr Health J. 2010;16(8):886–892. doi:10.26719/2010.16.8.886
   Google Scholar
• Alam MM, Sikdar P, Kumar A, Mittal A. Assessing adherence and patient satisfaction with medication. Int J Pharm Healthc Mark. 2018;12(4):409–432. doi:10.1108/IJPHM-10-2016-0053
   Web of Science ®Google Scholar
• Farrell M, Martin NK, Stockings E, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394(10209):1652–1667. doi:10.1016/S0140-6736(19)32230-5
   PubMed Web of Science ®Google Scholar